# Jade Biosciences, Inc. (JBIO)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/JBIO/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -96.13M | $ -67.74M | $ 628.0K | $ 439.92M |
| 2025 | $ 0 | $ -93.95M | $ -97.01M | $ 724.0K | $ 332.52M |
| 2024 | $ 0 | $ -73.23M | $ -70.13M | $ 417.0K | $ 76.43M |
| 2023 | $ 0 | $ -43.22M | $ -32.99M | $ 675.0K | $ 109.46M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.07 |
| Current Ratio | 14.93 |

## Other views

- [Metrics](https://sponda.capital/en/JBIO.md)
- [Charts](https://sponda.capital/en/JBIO/charts.md)
- [Compare](https://sponda.capital/en/JBIO/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.